StageSeed VC | Alive
Last Raised$14.8M | 1 yr ago
About Lumiere Therapeutics
Lumiere Therapeutics is committed to the research and development and industrialization of new gene-editing technologies. The company specializes in research fields such as gene editing, protein science, aging, and rare diseases. The company was founded in 2021 and is based in Suzhou, China.
Missing: Lumiere Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Lumiere Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Lumiere Therapeutics Frequently Asked Questions (FAQ)
When was Lumiere Therapeutics founded?
Lumiere Therapeutics was founded in 2021.
Where is Lumiere Therapeutics's headquarters?
Lumiere Therapeutics's headquarters is located at Unit E572, 5th Floor, Lecheng Plaza, Phase II, Biomedical Industrial Park, No. 218, Suzhou.
What is Lumiere Therapeutics's latest funding round?
Lumiere Therapeutics's latest funding round is Seed VC.
How much did Lumiere Therapeutics raise?
Lumiere Therapeutics raised a total of $14.8M.
Who are the investors of Lumiere Therapeutics?
Investors of Lumiere Therapeutics include Apricot Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.